ukmla MCQ (SBA): Obesity pharmacotherapy

Instant feedback + full explanation. One question, done properly.

MediumEndocrinologyObesity pharmacotherapyukmlamrcgp aktpaneprescribing safety assessment

A 48-year-old man with BMI 42 kg/m² and OSA on CPAP asks about pharmacological weight loss. No diabetes. Which is appropriate according to UK guidance?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: Obesity pharmacotherapy — Answer & Explanation | iatroX